TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06959277: Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

Sponsor: RxFunction Inc. · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 200 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$12,416,000

Rescue Site Savings

+$8,186,800

Unlock Full NCT06959277 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06959277 Rescue Dossier →